연구동향 분석

Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD® and VANTAFLU® in South Korean Subjects Aged ≥65 Years

유병욱 김창오 Allen Izu Ashwani Kumar Arora Esther Heijnen 2018년

논문상세정보
인용/피인용

' Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD® and VANTAFLU® in South Korean Subjects Aged ≥65 Years' 의 참고문헌

  • Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach
    Lambert ND [2012]
  • US Package Insert
  • The unmet need in the elderly: designing new influenza vaccines for older adults
  • The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy
    Cromer D [2014]
  • The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
    Podda A [2001]
  • The Korean Influenza National Immunization Program: History and Present Status
    윤재원 [2017]
  • Standard for re-examination of new drugs, etc. Notice 2010-94
  • Seasonal influenza vaccination of high-risk adults
    Loubet P [2016]
  • Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison
  • Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons
    Minutello M [1999]
  • Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato S [1999]
  • Mortality associated with influenza and respiratory syncytial virus in the United States
    Thompson WW [2003]
  • MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database
  • Influenza-associated hospitalizations in the United States
    Thompson WW [2004]
  • Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines
  • Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
    Nichol KL [2003]
  • Influenza control in the 21st century: Optimizing protection of older adults
    Monto AS [2009]
  • Influenza (Seasonal). Fact sheet 211
  • Immunosenescence of ageing
    Gruver AL [2007]
  • Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults
  • Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
  • FDA approves first seasonal influenza vaccine containing an adjuvant
  • Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
  • Effectiveness of influenza vaccine in the community-dwelling elderly
    Nichol KL [2007]
  • Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
    Frey SE [2014]
  • Association between obesity and vulnerability and serologic response to influenza vaccination in older adults
    Talbot HK [2012]
  • Ageing and infection
    Gavazzi G [2002]
  • A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis
    Banzhoff A [2003]